Literature DB >> 18505921

Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases.

Lei Xu1, Steven S Shen, Yujin Hoshida, Aravind Subramanian, Ken Ross, Jean-Philippe Brunet, Stephan N Wagner, Sridhar Ramaswamy, Jill P Mesirov, Richard O Hynes.   

Abstract

Metastasis is the deadliest phase of cancer progression. Experimental models using immunodeficient mice have been used to gain insights into the mechanisms of metastasis. We report here the identification of a "metastasis aggressiveness gene expression signature" derived using human melanoma cells selected based on their metastatic potentials in a xenotransplant metastasis model. Comparison with expression data from human melanoma patients shows that this metastasis gene signature correlates with the aggressiveness of melanoma metastases in human patients. Many genes encoding secreted and membrane proteins are included in the signature, suggesting the importance of tumor-microenvironment interactions during metastasis.

Entities:  

Mesh:

Year:  2008        PMID: 18505921      PMCID: PMC2756991          DOI: 10.1158/1541-7786.MCR-07-0344

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  26 in total

1.  A molecular signature of metastasis in primary solid tumors.

Authors:  Sridhar Ramaswamy; Ken N Ross; Eric S Lander; Todd R Golub
Journal:  Nat Genet       Date:  2002-12-09       Impact factor: 38.330

Review 2.  Cancer metastasis: building a framework.

Authors:  Gaorav P Gupta; Joan Massagué
Journal:  Cell       Date:  2006-11-17       Impact factor: 41.582

3.  Gene expression profiling predicts clinical outcome of breast cancer.

Authors:  Laura J van 't Veer; Hongyue Dai; Marc J van de Vijver; Yudong D He; Augustinus A M Hart; Mao Mao; Hans L Peterse; Karin van der Kooy; Matthew J Marton; Anke T Witteveen; George J Schreiber; Ron M Kerkhoven; Chris Roberts; Peter S Linsley; René Bernards; Stephen H Friend
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

Review 4.  Proteomic applications for the early detection of cancer.

Authors:  Julia D Wulfkuhle; Lance A Liotta; Emanuel F Petricoin
Journal:  Nat Rev Cancer       Date:  2003-04       Impact factor: 60.716

5.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.

Authors:  T Sørlie; C M Perou; R Tibshirani; T Aas; S Geisler; H Johnsen; T Hastie; M B Eisen; M van de Rijn; S S Jeffrey; T Thorsen; H Quist; J C Matese; P O Brown; D Botstein; P E Lønning; A L Børresen-Dale
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

6.  Genomic analysis of metastasis reveals an essential role for RhoC.

Authors:  E A Clark; T R Golub; E S Lander; R O Hynes
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

Review 7.  Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants-or both?

Authors:  Richard O Hynes
Journal:  Cell       Date:  2003-06-27       Impact factor: 41.582

8.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited.

Authors:  Isaiah J Fidler
Journal:  Nat Rev Cancer       Date:  2003-06       Impact factor: 60.716

Review 9.  Cancer spread and micrometastasis development: quantitative approaches for in vivo models.

Authors:  Ian C MacDonald; Alan C Groom; Ann F Chambers
Journal:  Bioessays       Date:  2002-10       Impact factor: 4.345

Review 10.  Dissemination and growth of cancer cells in metastatic sites.

Authors:  Ann F Chambers; Alan C Groom; Ian C MacDonald
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

View more
  118 in total

1.  Molecular sampling of prostate cancer: a dilemma for predicting disease progression.

Authors:  Andrea Sboner; Francesca Demichelis; Stefano Calza; Yudi Pawitan; Sunita R Setlur; Yujin Hoshida; Sven Perner; Hans-Olov Adami; Katja Fall; Lorelei A Mucci; Philip W Kantoff; Meir Stampfer; Swen-Olof Andersson; Eberhard Varenhorst; Jan-Erik Johansson; Mark B Gerstein; Todd R Golub; Mark A Rubin; Ove Andrén
Journal:  BMC Med Genomics       Date:  2010-03-16       Impact factor: 3.063

2.  PKCε promotes oncogenic functions of ATF2 in the nucleus while blocking its apoptotic function at mitochondria.

Authors:  Eric Lau; Harriet Kluger; Tal Varsano; KiYoung Lee; Immo Scheffler; David L Rimm; Trey Ideker; Ze'ev A Ronai
Journal:  Cell       Date:  2012-02-03       Impact factor: 41.582

3.  Metabolic enzymes expressed by cancer cells impact the immune infiltrate.

Authors:  Gautier Stoll; Margerie Kremer; Normal Bloy; Adrien Joseph; Maria Castedo; Guillaume Meurice; Christophe Klein; Lorenzo Galluzzi; Judith Michels; Guido Kroemer
Journal:  Oncoimmunology       Date:  2019-03-30       Impact factor: 8.110

4.  A Genome-Wide Loss-of-Function Screen Identifies SLC26A2 as a Novel Mediator of TRAIL Resistance.

Authors:  Lina Y Dimberg; Christina G Towers; Kian Behbakht; Taylor J Hotz; Jihye Kim; Susan Fosmire; Christopher C Porter; Aik-Choon Tan; Andrew Thorburn; Heide L Ford
Journal:  Mol Cancer Res       Date:  2017-01-20       Impact factor: 5.852

5.  Tanapoxvirus lacking a neuregulin-like gene regresses human melanoma tumors in nude mice.

Authors:  Tiantian Zhang; Yogesh R Suryawanshi; Dennis H Kordish; Helene M Woyczesczyk; David Jeng; Karim Essani
Journal:  Virus Genes       Date:  2016-10-13       Impact factor: 2.332

6.  HMG20A is required for SNAI1-mediated epithelial to mesenchymal transition.

Authors:  S Rivero; M Ceballos-Chávez; S S Bhattacharya; J C Reyes
Journal:  Oncogene       Date:  2015-02-02       Impact factor: 9.867

7.  MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway.

Authors:  Radoslav Janostiak; Navin Rauniyar; TuKiet T Lam; Jianhong Ou; Lihua J Zhu; Michael R Green; Narendra Wajapeyee
Journal:  Cell Rep       Date:  2017-12-05       Impact factor: 9.423

8.  A Targeted Quantitative Proteomic Approach Assesses the Reprogramming of Small GTPases during Melanoma Metastasis.

Authors:  Ming Huang; Tianyu F Qi; Lin Li; Gao Zhang; Yinsheng Wang
Journal:  Cancer Res       Date:  2018-08-02       Impact factor: 12.701

9.  Tissue inhibitor of metalloproteinase 1 expression associated with gene demethylation confers anoikis resistance in early phases of melanocyte malignant transformation.

Authors:  Tatiana I Ricca; Gangning Liang; Ana Paula M Suenaga; Sang W Han; Peter A Jones; Miriam G Jasiulionis
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

10.  Tumor transcriptome sequencing reveals allelic expression imbalances associated with copy number alterations.

Authors:  Brian B Tuch; Rebecca R Laborde; Xing Xu; Jian Gu; Christina B Chung; Cinna K Monighetti; Sarah J Stanley; Kerry D Olsen; Jan L Kasperbauer; Eric J Moore; Adam J Broomer; Ruoying Tan; Pius M Brzoska; Matthew W Muller; Asim S Siddiqui; Yan W Asmann; Yongming Sun; Scott Kuersten; Melissa A Barker; Francisco M De La Vega; David I Smith
Journal:  PLoS One       Date:  2010-02-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.